| Ambalal Sarabhai Enterprises Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500009 |
NSE Symbol : AMBASARABH |
P/E(TTM) : 27.83 |
|
ISIN Demat : INE432A01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.04 |
|
Book Value(₹) : 7.17 |
Market Cap(₹Cr) : 221.78 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.79 | 1.64 | 1.73 | 1.17 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.79 | 1.64 | 1.73 | 1.17 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.89 | 1.36 | 8.17 | 1.39 | 10.81 | 6.37 |
| Total Income | 2.89 | 2.15 | 9.81 | 3.12 | 11.98 | 6.37 |
| Total Expenditure | 0.94 | 2.42 | 2.82 | 8.03 | 3.74 | 1.79 |
| PBIDT | 1.95 | -0.28 | 6.99 | -4.91 | 8.24 | 4.58 |
| Interest | 0.09 | 0.08 | 0.07 | 0.05 | 0.10 | 0.09 |
| PBDT | 1.86 | -0.36 | 6.91 | -4.96 | 8.14 | 4.48 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | -0.21 | 0.21 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | 0.00 | 0.00 | -0.02 | -0.10 | -0.07 |
| Reported Profit After Tax | 1.84 | -0.38 | 6.88 | -4.96 | 8.43 | 4.31 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | -4.60 | 5.15 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.84 | -0.38 | 6.88 | -0.36 | 3.28 | 4.31 |
| EPS (Unit Curr.) | 0.24 | -0.05 | 0.90 | -0.64 | 1.10 | 0.56 |
| EPS (Adj) (Unit Curr.) | 0.24 | -0.05 | 0.90 | -0.64 | 1.10 | 0.56 |
| Calculated EPS (Unit Curr.) | 0.24 | -0.05 | 0.90 | -0.65 | 1.10 | 0.56 |
| Calculated EPS (Adj) (Unit Curr.) | 0.24 | -0.05 | 0.90 | -0.65 | 1.10 | 0.56 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.96 | -0.20 | 3.59 | -2.59 | 4.40 | 2.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.96 | -0.20 | 3.59 | -2.59 | 4.40 | 2.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | -35.44 | 426.22 | -283.82 | 704.27 | 0.00 |
| PBDTM(%) | 0.00 | -45.57 | 421.34 | -286.71 | 695.73 | 0.00 |
| PATM(%) | 0.00 | -48.10 | 419.51 | -286.71 | 720.51 | 0.00 |
